| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGGCGGAGUGUGGAAUUCUUCUCGGGAGGCAGUGCUGGGUCCUUUCCAC… | 783 nt | 0.5338 | |
| GGGCGGAGUGUGGAAUUCUUCUCGGGAGGCAGUGCUGGGUCCUUUCCAC… | 741 nt | 0.5385 | |
| AGUGUUCGGGACUGCCUCACGCUGUGCAGAGAAACAAAGAAGGGAGAUC… | 791 nt | 0.5322 |
This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]
A study in humans demonstrated that the MYL2 is significantly downregulated at the RNA level in the cardiomyocytes of individuals with Sudden Unexplained Death in Schizophrenia (SUD-SCZ), where it is associated with the pathogenesis of the condition as a gene involved in cardiac contractility and calcium homeostasis [Chen et al. DOI:10.1016/J.Forsciint.2025.112646]. In a separate study in mice, the MYL2 was identified as a protein-coding gene associated with sarcomeric function and was linked to chromatin immunoprecipitation clusters enriched in downregulated long non-coding RNAs following myocardial infarction [Ounzain et al. DOI:10.1093/eurheartj/ehu180]. A study in rats demonstrated that the MYL2 (Myl2) is a cardiac development-associated RNA marker, with its expression significantly downregulated in adult cardiac fibroblasts compared to both neonatal and fetal fibroblasts, indicating its role in age-dependent transcriptomic shifts [Perreault et al. DOI:10.1152/physiolgenomics.00074.2021].